SKYESkye Bioscience, Inc.同业对比
Skye Bioscience, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SKYE本股 | $47M#6 | — | — | — | — | -110.5%#12 | — | — | — | — | -89.3%#3 | — |
| GANX | $52M#1 | — | 4.6x#9 | 941.2x#7 | -58.4%#4 | 1.2%#7 | -33908.5%#5 | -178.5%#8 | — | — | -39.4%#1 | — |
| SER | $50M#2 | — | — | 386.9x#4 | 132.1%#2 | -72.2%#10 | -18478.5%#4 | — | — | 5#1 | — | — |
| IBIO | $50M#3 | — | 0.6x#2 | 501.0x#5 | -75.0%#5 | -78.7%#11 | -35141.0%#6 | -38.3%#2 | — | — | — | — |
| CLNN | $50M#4 | — | — | 250.2x#3 | -41.5%#3 | 33.6%#3 | -11541.5%#3 | — | — | — | — | — |
| HOWL | $49M#5 | — | 3.0x#7 | — | — | 13.7%#5 | — | -373.3%#9 | -229.9%#2 | — | — | — |
| ATNM | $47M#7 | 4.3x#2 | 1.5x#6 | 520.5x#6 | — | 11.4%#6 | -40274.4%#7 | -111.8%#6 | — | — | — | — |
| CTOR | $47M#8 | — | 1.2x#5 | — | — | -17.1%#8 | — | -61.3%#5 | — | — | -71.8%#2 | — |
| ELTX | $47M#9 | — | 5.9x#10 | 20.2x#2 | -91.9%#6 | 23.8%#4 | -1639.0%#2 | -498.6%#10 | — | — | — | — |
| XLO | $46M#10 | — | 0.6x#4 | 1.1x#1 | 589.9%#1 | 39.8%#2 | -95.9%#1 | -48.5%#3 | — | — | — | — |
| BMEA | $46M#11 | — | 3.8x#8 | — | — | 55.4%#1 | — | -509.2%#11 | — | — | — | — |
| AZTR | $46M#12 | 37.7x#3 | 6.2x#11 | — | -100.0%#7 | -22.2%#9 | — | -149.4%#7 | — | — | — | — |
| APUS | $4M#14 | — | 0.0x#1 | — | — | -331.7%#14 | — | -5.6%#1 | -11.2%#1 | — | — | — |
| DWTX | $42M#13 | 0.7x#1 | 0.6x#3 | — | — | -177.4%#13 | — | -50.1%#4 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-02。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议